1. Home
  2. CNTA vs MEOH Comparison

CNTA vs MEOH Comparison

Compare CNTA & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • MEOH
  • Stock Information
  • Founded
  • CNTA 2020
  • MEOH 1968
  • Country
  • CNTA United Kingdom
  • MEOH Canada
  • Employees
  • CNTA N/A
  • MEOH N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • MEOH Major Chemicals
  • Sector
  • CNTA Health Care
  • MEOH Industrials
  • Exchange
  • CNTA Nasdaq
  • MEOH Nasdaq
  • Market Cap
  • CNTA 2.2B
  • MEOH 2.5B
  • IPO Year
  • CNTA 2021
  • MEOH N/A
  • Fundamental
  • Price
  • CNTA $12.30
  • MEOH $27.02
  • Analyst Decision
  • CNTA Strong Buy
  • MEOH Buy
  • Analyst Count
  • CNTA 9
  • MEOH 8
  • Target Price
  • CNTA $25.63
  • MEOH $49.50
  • AVG Volume (30 Days)
  • CNTA 1.2M
  • MEOH 698.0K
  • Earning Date
  • CNTA 05-12-2025
  • MEOH 04-28-2025
  • Dividend Yield
  • CNTA N/A
  • MEOH 2.74%
  • EPS Growth
  • CNTA N/A
  • MEOH N/A
  • EPS
  • CNTA N/A
  • MEOH 2.39
  • Revenue
  • CNTA N/A
  • MEOH $3,719,829,000.00
  • Revenue This Year
  • CNTA N/A
  • MEOH $17.69
  • Revenue Next Year
  • CNTA N/A
  • MEOH $5.92
  • P/E Ratio
  • CNTA N/A
  • MEOH $11.10
  • Revenue Growth
  • CNTA N/A
  • MEOH N/A
  • 52 Week Low
  • CNTA $7.75
  • MEOH $25.46
  • 52 Week High
  • CNTA $19.09
  • MEOH $56.43
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 40.90
  • MEOH 30.64
  • Support Level
  • CNTA $11.50
  • MEOH $26.47
  • Resistance Level
  • CNTA $12.82
  • MEOH $28.01
  • Average True Range (ATR)
  • CNTA 1.21
  • MEOH 2.00
  • MACD
  • CNTA 0.03
  • MEOH -0.04
  • Stochastic Oscillator
  • CNTA 50.95
  • MEOH 15.84

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

Share on Social Networks: